McKinsey 27.2.23 J. Abraham Associate Partner, & other McKinsey Partners, provide a very detailed overview of why McKinsey considers telcos to be a major beneficiary (which will considerably improve their efficiency, reduce staff numbers, & thus much greater profits) of the coming AI revolution.
They said"Artificial intelligence, when deployed at scale, can help telcos protect core revenues and drive margin growth. But capturing this opportunity will require a wholly different approach.Artificial intelligence (AI) is unlocking use casesthat are transforming industries across a wide swath of the world’s economy. From infrastructure that “self-heals” to radically reimagined (and touchless) customer service and experience; from large scale hyper-personalization to automatically created marketing messages and images leveraging Generative AI tools like ChatGPT—it is all a reality today. These AI solutions can powerfully augment and sometimes radically outperform most traditional business roles.
The impact from these solutions is becoming evident. AI leaders—the top quintile of companies that have taken the McKinsey Analytics Quotient assessment—have experienced a five-year revenue CAGR that is 2.1 times higher than that of peers and a total return to shareholders that is 2.5 times larger (all my emphases)"
https://www.mckinsey.com/industries/technology-media-and-telecommunications/our-insights/the-ai-native-telco-radical-transformation-to-thrive-in-turbulent-times
(Click on "Esc" tab, immediately after article appears, to open the article. Warning: Long Read)
- Forums
- ASX - By Stock
- TLS
- Outperform market
TLS
telstra group limited
Add to My Watchlist
0.00%
!
$4.83

Outperform market, page-62
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.83 |
Change
0.000(0.00%) |
Mkt cap ! $54.93B |
Open | High | Low | Value | Volume |
$4.82 | $4.85 | $4.81 | $42.76M | 8.854M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
125 | 447655 | $4.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 384840 | 78 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
114 | 436564 | 4.820 |
51 | 368384 | 4.810 |
43 | 481122 | 4.800 |
26 | 523270 | 4.790 |
23 | 109444 | 4.780 |
Price($) | Vol. | No. |
---|---|---|
4.830 | 394503 | 78 |
4.840 | 261724 | 50 |
4.850 | 661291 | 55 |
4.860 | 512476 | 24 |
4.870 | 273698 | 20 |
Last trade - 14.48pm 27/06/2025 (20 minute delay) ? |
Featured News
TLS (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online